Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed
- Development stage
- Phase 3
- Lead developer
- CanSino Biologics
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
TDCP is a Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed, developed by CanSino Biologics Inc. This vaccine is designed to provide immunity against diphtheria, tetanus, and pertussis (whooping cough) by stimulating the immune system to produce antibodies against antigens from *Corynebacterium diphtheriae*, *Clostridium tetani*, and *Bordetella pertussis*. It is an acellular DPT combination vaccine.
- Other names
- Tdcp Adolescent and Adultabsorbed diphtheria, tetanus and acellular pertussis (components) combined vaccinereduced diphtheria toxoid, tetanus toxoid and acellular pertussis vaccineTdcp vaccine (CanSino Biologics)
02
Targets
BCR-DTP (B-cell receptor repertoire specific for diphtheria, tetanus, and pertussis antigens)
Beyond the preview
Go deeper on Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed.